AbbVie completed an $8.75 billion note offering to partially fund its acquisition of Apogee Therapeutics.
PUBLIC · ABBVAug 18, 2026
Amount Raised
$8.75 Billion
Round Type
Venture
North ChicagoManufacturingBiotechnologyHealthcareHealth CareTherapeuticsPharmaceuticalBiopharma
Description
AbbVie completed an $8.75 billion underwritten notes offering for its Apogee acquisition. The proceeds will cover cash consideration, related fees, and general purposes. Fixed coupons range from 4.500% to 6.100%. The notes are unsecured and ranked equally with other senior debt.
Company Information
Company
AbbVie Inc.
Location
1 North Waukegan Road
North Chicago, Illinois, United States
About
Venture capital subsidiary of Abbvie
Fundz sees it the moment AbbVie Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.